Effects of filgrastim on granulopoietic cells of mice pretreated with methotrexate

Biocell

Volumn 29, Issue 1, 2005, Pages 7-14

  Barrios, Lilian ^a   Poletti, Oscar Héctor ^a  

^a UNIVERSIDAD NACIONAL DEL NORDESTE   (Argentina)

Author keywords

Bone marrow; Filgrastim; Granulopoiesis; Methotrexate; Spleen

Indexed keywords

CYTOTOXIC AGENT; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GRANULOCYTE; MICROENVIRONMENT; MOUSE; NEUTROPHIL; NONHUMAN; SPLEEN CELL; STEM CELL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; FILGRASTIM; GRANULOCYTE PRECURSOR CELLS; GROWTH SUBSTANCES; HEMATOPOIESIS; METHOTREXATE; MICE; NEUTROPENIA; NEUTROPHILS; SPLEEN;

ANIMALIA;

EID: 18844415052     PISSN: 03279545     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Barrios L, Agustini MI, Poletti OH, Juaristi J, Brandan NC (1998). Effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on murine bone marrow and spleen erythropoiesis. Acta Physiol Pharmacol Ther Latinoam 48: 18-24.
2. Barrios L, Poletti OH, Agustini MI (2000). The influence of recombinant human granulocyte colony-stimulating factor on granulopoiesis in mice recovering from cyclophosphamide treatment. Methods Find Exp Clin Pharmacol 22: 275-280.
3. Blau CA, Neff T, Papayannopoulou T (1996). The hematological effects of folate analogs: implications for using the dihydrofolate reductase gene for in vivo selection. Hum Gene Ther 7: 2069-2078.
4. Boggs DR (1984). The total marrow mass of the mouse: A simplified method of measurement. Am J Hematol 16: 277-286.
5. Bogliolo GV, Lerza RA, Mencoboni MP, Saviane AG, Pannaciulli IM (1988). Toxicity of trimetrexate on hemopoietic progenitor cells in normal mice. Anticancer Res 8: 229-231.
6. Bower M, Rustin GJ, Newlands ES, Holden L, Short D, Foskett M, Bagshawe KD (1998). Chemotherapy for gestational trophoblastic tumors hastens menopause by 3 years. Eur J Cancer 34: 1204-1207.
7. Bungart B, Loeffler M, Goris H, Dontje B, Diehl V, Nijhof W (1990). Differential effects of recombinant human colony stimulating factor (rh G-CSF) on stem cells in marrow, spleen and peripheral blood in mice. Br J Haematol 76: 174-179.
8. Burgess AW, Metcalf D, Russell SH, Nicola NA (1980). Granulocyte/ macrophage-, megakaryocyte-, eosinophil- and erythroid-colony-stimulating factors produced by mouse spleen cells. Biochem J 185: 301-314.
9. Colleoni M, Rocca A, Sandri MT, Zorzino L, Masci G, Nole F, Peruzzotti G, Robertson C, Orlando L, Cinieri S, de BF, Viale G, Goldhirsch A (2002). Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. Ann Oncol 1:73-80.
10. Edelman MJ, Meyers FJ, Miller TR, Williams SG, Candour-Edwards R, deVere White RW (2000). Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation. Urology 55: 521-525.
11. Goris H, Bungart B, Loeffler M, Schmitz S, Nijhof W (1990). Migration of stem cells and progenitors between marrow and spleen following thiamphenicol treatment of mice. Exp Hematol 18: 400-407.
12. Hsu CH, Chen J, Wu CY, Cheng AL, Pu YS (2001). Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma. Anticancer Res 21:711-715.
13. Iqbal MP, Burney IA, Sultana F, Mehboobali N, Siddiqui T (2000). Increased levels of multiple forms of dihydrofolate reductase in peripheral blood leucocytes of cancer patients receiving haematopoietic colony-stimulating factors: interim analysis. Exp Mol Med. 32: 84-87.
14. Iscove NN, Sieber F (1975). Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture. Exp Hematol 3: 32-43.
15. Kuijpers AL, van de Kerkhof PC (2000). Risk-benefit assessment of methotrexate in the treatment of severe psoriasis. Am J Clin Dermatol 1:27-39.
16. Lin JC, Jan JS, Hsu CY, Wong DY (1999). High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin. Cancer 85: 1430-1438.
17. Morrison SJ, Wright DE, Weissman IL (1997). Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc Natl Acad Sci USA 94: 1908-1913.
18. Pannacciulli I, Massa G, Bogliolo G, Ohio R, Sobrero A (1982). Effects of high-dose methotrexate and leucovorin on murine hemopoietic stem cells. Cancer Res 42: 530-534.
19. Papadopoulos NG, Alamanos Y, Papadopoulos IA, Tsifetaki N, Voulgari PV, Drosos AA (2002). Disease modifying antirheumatic drugs in early rheumatoid arthritis: a long term observational study. J Rheumatol. 29: 261-266.
20. Shimamura M, Kobayashi Y, Yuo A, Urabe A, Okabe T, Komatsu Y, Itoh S, Takaku F (1987). Effect of human recombinant granulocyte colony-stimulating factor on hematopoietic injury in mice induced by 5-fluorouracil. Blood. 69: 353-355.
21. Stromhaug A, Warren DJ, Slordal L (1995). Effect of methotrexate on murine bone marrow cells in vitro: evidence of a reversible antiproliferative action. Exp Hematol 23: 439-443.
22. Stromhaug A, Warren DJ (2000). A comparison of the effects of nine folate analogs on early and late murine hematopoietic progenitor cells in vitro. Cancer Chemother Pharmacol 45: 450-456.
23. Vogler WR, Mingioli ES, Garwood FA (1973). The effect of methotrexate on granulocytic stem cells and granulopoiesis. Cancer Res 33: 1628-1633.